European Archives - Page 126 of 1393 - European Medical Journal

food allergy

Early Food Introduction Reduces Paediatric Food Allergy

These declines were observed regardless of atopic dermatitis diagnosis, indicating that early food introduction benefits both high-risk and general populations.

High Cure Rates in HCV Treatment Achieved

The DRIVE-C study in Haiphong, Vietnam, evaluated a community-based strategy to screen PWID for HCV and provide access to direct-acting antivirals.

Atrial Cardiomyopathy Raises Stroke and Heart Risk

Researchers find atrial cardiomyopathy strongly linked with atrial fibrillation, stroke, and heart failure, suggesting new prevention strategies in heart health.

Monosodium Urate Crystals Dissolve at Similar Rates in Joints and Tendons, DECT Study Finds

Monosodium Urate Crystals Dissolve at Similar Rates in Joints and Tendons

A dual-energy CT study shows monosodium urate crystals clear at similar rates in joints and tendons during gout treatment.

Acne Drug Sparks New Hope for Male Fertility

Acne Drug Sparks New Hope for Male Fertility

A common acne drug, isotretinoin, may help restore sperm production in infertile men, offering new fertility hope.

Long COVID Risk in Children Doubles After SARS-CoV-2 Reinfection

Children face over twice the risk of paediatric long COVID after SARS-CoV-2 reinfection, highlighting urgent needs for prevention.

Lactate-to-Glucose Ratio Identified as Key Predictor of Mortality in Cirrhosis

Lactate-to-Glucose Ratio Identified as Key Predictor of Mortality in Cirrhosis

A study of over 3,800 ICU patients finds the lactate-to-glucose ratio predicts short-term mortality in cirrhosis, offering a simple new tool for bedside risk assessment.

Early-Life Stress and Psoriasis Development Insights

This new study examined whether stressful life factors in early childhood increase the likelihood of developing psoriasis later in life.

Ketamine for Depression Underwhelms in New Study

Ketamine for Depression Underwhelms in New Study

The KARMA-Dep 2 trial finds ketamine for depression no more effective than placebo in treating hospitalised patients with major depression.

US-RASP Benefits for Large-Volume BPH Patients

US-RASP Benefits for Large-Volume BPH Patients

US-RASP has emerged as a promising alternative that maintains sexual function while providing comparable outcomes in urinary symptom relief.